Citigroup Inc Codex Dna, Inc. Transaction History

Citigroup Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.3 - $2.15 $205 - $339	-158 Reduced 96.34%	6 $0
Q4 2022 Feb 09, 2023	SELL	$1.12 - $1.69 $388 - $586	-347 Reduced 67.91%	164 $0
Q3 2022 Nov 10, 2022	SELL	$1.7 - $2.36 $297 - $413	-175 Reduced 25.51%	511 $1,000
Q2 2022 Aug 10, 2022	SELL	$1.8 - $6.45 $1,333 - $4,779	-741 Reduced 51.93%	686 $1,000
Q1 2022 May 12, 2022	SELL	$4.12 - $10.36 $5,813 - $14,617	-1,411 Reduced 49.72%	1,427 $8,000
Q4 2021 Feb 10, 2022	BUY	$6.31 - $11.96 $12,329 - $23,369	1,954 Added 221.04%	2,838 $31,000
Q3 2021 Nov 10, 2021	BUY	$10.15 - $19.88 $8,972 - $17,573	884 New	884 $10,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.